An miRNA-based gene therapy approach to target mutated SOD1 in key cell types in amyotrophic lateral sclerosis (ALS)

Vilmont, V.; Aebischer, J.; Rochat, C.; Schneider, B. L.

[en] Maintenance on Monday, August 4 from 10:00 to 12:00 – brief service interruptions may occur. Thank you for your patience and understanding / [fr] Maintenance le lundi 4 août de 10h à 12h – de courtes interruptions de service sont possibles. Merci de votre patience et de votre compréhension.

conference paper

An miRNA-based gene therapy approach to target mutated SOD1 in key cell types in amyotrophic lateral sclerosis (ALS)

Vilmont, V.

•

Aebischer, J.

•

Rochat, C.

December 1, 2018

Human Gene Therapy

Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy